COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib.
Título
COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib.
Autor
E Caradec, D Mouren, M Zrounba, L-D Azoulay, C Blandin, S Ivanoff, V Levy, P-Y Brillet, H Nunes, Y Uzunhan
Fecha
2020
Materia
covid-19, SARS-CoV-2, idiopathic pulmonary fibrosis, JAK inhibitors
Identificador
10.1016/j.resmer.2020.100799
Fuente
Respiratory medicine and research
Archivos
Colección
Citación
E Caradec, D Mouren, M Zrounba, L-D Azoulay, C Blandin, S Ivanoff, V Levy, P-Y Brillet, H Nunes, Y Uzunhan, “COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib.,” SOCICT Open, consulta 23 de abril de 2026, https://socictopen.socict.org/items/show/8200.
Position: 17857 (17 views)